Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Importantly, we further demonstrated that overexpressing PHD2 attenuated inflammation in colon cancer xenograft mice through weakening accumulation of myeloid-derived suppressor cells (MDSCs) and M2-like tumor-associated macrophages (TAMs), as well as secretions of pro-inflammatory cytokines including G-CSF, TNF-α, IL-6, IL-8, IL-1β, and IL-4.
|
31838134 |
2020 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Loss of zinc-finger protein 143 contributes to tumour progression by interleukin-8-CXCR axis in colon cancer.
|
30933430 |
2019 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
On the other hand, we reveal an unfavorable PDT effect, connected with increase of IL-8 secretion by both treated colon cancer cell lines, which implicates the use of adjuvant immunotherapy against IL-8, as a part of individualized colon cancer therapy.
|
30016752 |
2018 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Stromal <i>miR-20a</i> controls paracrine CXCL8 secretion in colitis and colon cancer.
|
29560130 |
2018 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
CXCL8 induces epithelial-mesenchymal transition in colon cancer cells via the PI3K/Akt/NF-κB signaling pathway.
|
28259918 |
2017 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Loss of dual-specificity phosphatase-2 promotes angiogenesis and metastasis via up-regulation of interleukin-8 in colon cancer.
|
28026024 |
2017 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Thus, the potential benefit of the use of a combination of camptothecin-11 with other chemical drugs with inhibitory effects on IL-8 expression, should be paid more attention in treating colon cancer.
|
27878250 |
2017 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Additionally, we revealed that <i>IL32</i> expression levels are enhanced by hypoxia and inflammation-related factors in HT-29 CC cells as well as that IL-32α is involved in the upregulation of inflammation (<i>IL8, TNF</i>, and <i>CCL2</i>) and extracellular matrix (ECM) remodeling (<i>SPP1</i> and <i>MMP9</i>) genes in HT-29 cancer cells.
|
28811968 |
2017 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, cycling hypoxia-specific inflammatory phenotype, characterized by a simultaneous (baculoviral inhibitor of apoptosis repeat-containing 5)(low)/PTGS2(high)/ICAM-1(high)/IL-6(high)/IL-8(high) expression, is associated with a poor prognosis in human colon cancer.
|
25622900 |
2015 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Infusions exhibited the potential to inhibit cell growth and to reduce IL-8 levels in HT29 colon and PC3 prostate cancer cells.
|
24001836 |
2014 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Increased expression of IL-8 in the tumour microenvironment enhanced colon cancer growth and metastasis.
|
22617157 |
2012 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Therefore, MCP-1, VEGF-A, TNF-α, IL-1β, and IL-8 are suggested to be associated with differentiation of human monocytes into tumor-associated macrophages at human colon cancer sites.
|
21873165 |
2011 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Expression of GRO-2, GRO-3, and IL-8 was significantly increased in colon cancer as compared to normal colon tissue.
|
20162422 |
2010 |
Colon Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Further analysis of the topological architecture of the network identified three known hub cancer genes [interleukin 8 (IL8) (p approximately 0), desmin (DES) (p = 2.71 x 10(-6)) and enolase 1 (ENO1) (p = 4.19 x 10(-5))], while two novel hub genes [RNA binding motif protein 9 (RBM9) (p = 1.50 x 10(-4)) and ribosomal protein L30 (RPL30) (p = 1.50 x 10(-4))] may define new central elements in the gene network specific to colon cancer.
|
18691435 |
2008 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The expression pattern of these sPLA2s appeared to be linked respectively to the overexpression of interleukin-8, defensin alpha6, survivin and matrilysin, and downregulation of SFRP-1 and RLPA-1, all these genes being associated to colon cancer.
|
18212756 |
2008 |
Colon Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
No association was found between IL-8 -251 A/T genotypes and IL-8 mRNA expression in tumour and corresponding normal mucous tissue, as well as susceptibility to sporadic colon cancer.
|
18628251 |
2008 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Adherent and invasive IBD and colon cancer E. coli isolates also elicit a flagellin-independent IL-8 response that may be relevant when the mucosal barrier is intact.
|
17941093 |
2008 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
In this study, we investigated the effects of caffeine on HIF-1 protein accumulation and on VEGF and IL-8 expression in the human colon cancer cell line HT29 under hypoxic conditions.
|
17488804 |
2007 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Interestingly, however, SARS-CoV strongly induced the chemokines IP-10 and IL-8 in the colon carcinoma cell line Caco-2, but not in the embryonic kidney cell line 293.
|
16571117 |
2006 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Thus, we investigated the effect of oxysterols, including 25-hydroxycholesterol and 7beta-hydroxycholesterol, on IL-1beta-induced IL-8 production in Caco-2 cells (a human colon carcinoma cell line).
|
17086498 |
2005 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
A neutralizing antibody to IL-8 substantially inhibited angiogenesis and tumor growth in DLD-1(HIF-kd) but not DLD-1(HIF-wt) xenografts, verifying the functional significance of this IL-8 response.
|
16127434 |
2005 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Relative to normal controls, the expression of several genes, including PPAR-gamma, SAA1, and IL-8 were significantly altered in the macroscopically normal rectosigmoid mucosa from individuals with a family history of colon cancer.
|
15746039 |
2005 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
TNFalpha and IL-8 regulate the expression and function of CD44 variant proteins in human colon carcinoma cells.
|
12090473 |
2002 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
We observed significant differences in the invasive potential of colon carcinoma cells expressing different levels of IL-8.
|
11595728 |
2001 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The effect of modulating IL-8 activity upon the growth of the colon carcinoma cell lines HCT116A, HT29 and CaCo2 was investigated.
|
10623446 |
2000 |